5
total announcements
BLISSGVS.NS · 15 min delayed
Bliss GVS Pharma Limited
Bliss GVS Pharma Limited announced a book closure period from July 9, 2026, to July 15, 2026, for its 41st Annual General Meeting. This period will also serve as the record date for determining eligible shareholders for the final dividend for the financial year ended March 31, 2026. If approved at the AGM on July 15, 2026, the final dividend will be paid on or before August 14, 2026.
Bliss GVS Pharma Limited
Bliss GVS Pharma Limited has announced a record date of July 08, 2026, for the purpose of its Final Dividend for the financial year ended March 31, 2026. The Register of Members and Share Transfer Books will be closed from July 09, 2026, to July 15, 2026, for the 41st Annual General Meeting and dividend payment. If approved at the AGM, the dividend will be distributed to eligible shareholders on or before August 14, 2026.
Bliss GVS Pharma Limited
Bliss GVS Pharma Limited announced its 41st Annual General Meeting (AGM) will be held on July 15, 2026, via Video Conference. Key agenda items include the adoption of the audited financial statements for FY2025-2026, the proposed declaration of a final dividend of 100% (INR 1.00 per equity share), and the re-appointment of Mr. Narsimha Shibroor Kamath as Managing Director & CEO. The record date for the dividend is set for July 08, 2026, with payment expected by August 14, 2026, if approved.
Bliss GVS Pharma Limited
Bliss GVS Pharma Limited has informed the exchanges about a communication sent to its shareholders regarding the tax deduction on dividend income. Following the Finance Act, 2020, dividend distribution tax has been abolished, and dividend income is now taxable directly in the hands of shareholders. The company has emailed shareholders with registered IDs, explaining the new tax deduction process. This communication details the formalities shareholders must follow to ensure appropriate tax deduction on any dividend declared at the 41st Annual General Meeting for FY 2026-2027. Investors should review this information to understand their tax obligations for future dividend payouts.
Bliss GVS Pharma Limited
Bliss GVS Pharma Limited has informed the Exchange about the intimation of its 41st Annual General Meeting (AGM) through newspaper publications dated June 19, 2026. The AGM is scheduled to take place on Wednesday, July 15, 2026, at 11:00 a.m. (IST). It will be conducted virtually via Video Conferencing (VC) or Other Audio Visual Means (OAVM). This routine announcement ensures shareholders are duly informed about the upcoming meeting where significant company matters are typically discussed and voted upon, in compliance with SEBI Listing Regulations.